Solco Biomedical Co LtdA043100:KOE

1,020
130.00 / 14.61%
13.95m
36.73%
--
Latest price in KRWToday's changeShares traded1 year changeBeta
Data delayed at least 20 minutes, as of Sep 30 2014 16:00 BST.

About the company

32.60bn-5.59bn1995176
Revenue in KRW (TTM)Net income in KRWIncorporatedEmployees
IndustryHealth Care Equipment & ServicesLocation
Solco Biomedical Co Ltd
34-6, Geumam-Ri, Seotan-Myeon
PYEONGTAEK451852
South Korea
KOR
Phone+82 316104000Fax+82 316636520Websitehttp://eng.solco.co.kr
Solco Biomedical Co., Ltd. is a Korea-based company mainly engaged in the manufacture of medical equipment and healthcare products. The Company operates its business through two divisions: medical equipment division, which produces implants used in trauma, spine, hip joints and knee joints, and surgical instruments and disposable appliances, such as forceps, scissors, needle holders, hemostatic forceps, intestinal forceps, retractors, hooks, trocars, suction tubes, mouth gags, vein strippers, probes and other products, and healthcare division, which produces household therapy equipment, such as heating mats, water ionizers, air cleaners and others. The Company distributes its products within domestic market and to overseas markets.

Mergers & acquisitions

There are no recent mergers or acquisitions for Solco Biomedical Co Ltd.
Data delayed at least 20 minutes, as of Sep 30 2014 16:00 BST.

Peer analysis

Company Revenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings
(TTM)
Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excluding
extraordinary items (TTM)
EPS (including
extraordinary items) (TTM)
Revenue per
share (TTM)
Book value per
share (MRQ)
Asset turnover
(TTM)
Inventory turnover
(TTM)
Receivables turnover
(TTM)
Revenues per
employee (TTM)
Return on
average
assets
(TTM)
Return on
average
assets
(5 yr average)
Return on
investment
(TTM)
Return on
investment
(5 yr average)
Gross margin (TTM)Gross margin (5 yr average)Net profit margin (TTM)Net Profit margin (5 Yr Average)Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio (5 yr average)Revenue
(Year-over-year change%)
Revenue
(5 yr growth rate)
Net income
(Year-over-year change%)
Net income
(5 Yr growth rate)
Capital
expenditure
(5 Yr growth rate)
Dividend
(5 yr growth rate)
Wooridul Huebrain Ltd
8.86bn-5.50bn20.24bn36--1.52--2.28-686.1284-686.12841,104.131,670.910.32192.601.45---19.9746---27.945--28.89---62.0539--2.08-23.87650.3185---44.1367--28.78------
KM CORPORATION
97.78bn1.65bn35.50bn20619.680.54957.990.363184.41172.0010,906.436,605.740.98434.163.99384,945,0001.827.572.707.5717.2317.351.854.071.5716.920.202413.117.8816.303.311.13-3.2353--
Young In Frontier Co Ltd
17.94bn479.98m35.99bn8075.002.2546.922.0127.2727.271,016.27909.86------221,498,500---1.1383---1.138326.7121.862.68-1.04682.55--0.00--14.544.29129.02---47.862--
Wonik Co Ltd
59.14bn10.13bn39.99bn563.510.84233.600.6762943.47950.365,485.283,929.550.55923.733.351,019,665,0009.685.4324.585.4319.6423.2917.303.930.3075--0.58840.00-11.6423-6.75871,325.23-11.6553-7.558--
WINNOVA CO Ltd
19.25bn-14.20bn47.04bn100--1.74--2.44-477.9151-477.9151457.23493.500.33531.871.08194,475,600-24.7137-9.5959-48.7253-9.5959-6.477222.51-73.7142-6.91371.05-21.22570.2882---40.21724.38-310.9182--7.15--
Metabiomed Co Ltd
59.89bn-619.19m55.33bn169--1.2723.130.9239-40.9165-49.86543,073.372,495.520.5504.934.75371,958,800-0.57274.08-0.91734.0831.4439.30-1.04144.870.50140.41570.558115.2143.6427.83-21.8317-5.153425.84-13.852
Solco Biomedical Co Ltd
32.60bn-5.59bn55.60bn176--1.84--1.71-89.529-89.529522.21482.500.50851.504.06172,491,900-9.9669-9.599-17.2289-9.59930.5035.16-19.6024-12.37520.5873-3.3530.4278---10.76643.0337.59---0.847--
CU Medical Systems Inc
24.48bn-515.08m57.21bn138--1.5139.522.34-87.6227-87.62273,702.975,717.410.40211.421.17172,367,500-0.7376---0.996--47.02---1.8342--1.410.19240.3582--9.37---98.2151------
PJ Electronics Co., Ltd.
113.11bn7.55bn74.80bn2709.910.88947.740.6613754.52754.5211,311.418,409.751.114.386.55402,541,3007.3812.499.0712.498.0611.216.678.732.07--0.0018.911.6711.97-2.898937.07-19.6785.92
Shin Hung Co Ltd
124.16bn3.29bn79.39bn32123.950.996712.060.6394345.29345.2913,044.738,297.570.94042.786.37--2.442.593.592.5925.3420.972.601.480.64322.870.215250.02-19.2423-5.022938.96-6.5717-41.72280.00
Dio Corp
69.09bn-10.84bn91.79bn305--2.36--1.33-960.9916-960.99166,133.863,259.410.64612.461.95220,746,300-10.268-3.8772-12.2064-3.877249.8852.14-15.8925-5.80332.04-0.31940.5957--25.259.49-191.4539---24.865--
IntroMedic Co Ltd
11.09bn2.09bn99.38bn6043.186.1341.118.96327.72327.721,631.582,306.52------188,003,200--------77.55--18.87--14.795.730.00--23.73--421.30------
CUREXO INC.
28.23bn-8.06bn110.65bn33--4.16--3.92-303.0307-303.03071,061.1986.950.63222.302.76830,338,800-36.3852-40.5565-52.6727-40.556515.4921.69-57.5555-57.73881.41-20.2830.297--28.051.4536.39------
Data as of Oct 02 2014. Currency figures normalised to Solco Biomedical Co Ltd's reporting currency: Republic of Korean Won KRW.

Institutional shareholders

HolderShares% Held
Dimensional Fund Advisors LP
as of 31 Aug 2014
360.55k0.58%
0.58%
Per cent of shares
held by top holders
Data from 30 Jun 2014 - 30 Jun 2014Source: FactSet Research Systems Inc.
© Thomson Reuters Click for restrictions.

All markets data located on FT.com is subject to the FT Terms & Conditions.

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.